A Phase 2B Study of Bms-790052 in Combination With Peg-Interferon Alfa-2a and Ribavirin in Treatment Naive . . Grant uri icon

Overview

total award amount

  • 17016

direct costs

  • 13613.2

sponsor award id

  • AI444-010-061

Background

Time

date/time interval

  • August 11, 2010 - August 11, 2016

Identity

PeopleSoft Contract Number

  • 00078909

local award id

  • 00078909